New hope for lung transplant patients: experimental drug aims to prevent organ rejection
NCT ID NCT06948097
Summary
This early-stage study is testing whether fostamatinib, an oral medication, is safe for lung transplant patients who develop antibodies against their new lungs. Thirty adult participants will take either the study drug or a placebo pill for eight weeks while continuing their standard transplant care. Researchers want to see if the drug can help prevent antibody-mediated rejection and clear harmful antibodies without causing serious side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inova Health System Foundation
Falls Church, Virginia, 22042, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Stanford University School of Medicine
Stanford, California, 94305, United States
-
University of Utah Health
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.